Barinthus Biotherapeutics plc (BRNS) — Cash Flow Quality Index
Barinthus Biotherapeutics plc (BRNS) has a Cash Flow Quality Index of 1.45x as of September 2022. Operating cash flow of $11.88 Million exceeds net income of $8.22 Million, indicating high earnings quality where cash backs reported profits. Also explore Barinthus Biotherapeutics plc total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Barinthus Biotherapeutics plc Cash Flow Quality Index (2022–2022)
Historical Cash Flow Quality Index for Barinthus Biotherapeutics plc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Barinthus Biotherapeutics plc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Barinthus Biotherapeutics plc (2022–2022)
Year-by-year earnings quality comparison for Barinthus Biotherapeutics plc. For live market cap and the full company financial profile, see BRNS market cap overview.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -2.71x | $-14.43 Million | $5.32 Million | — |